Showing results (1-10 of 180) with videos related to
Sort By:
Pageof 18
Current Opinion in Obstetrics & Gynecology|February 1, 1996
Prognosis and management of borderline tumours of the ovaryC Tropé, J KaernSeminars in Oncology|June 20, 1998
Management of borderline tumors of the ovary: state of the artC Tropé, J KaernEuropean Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 9, 2006
Primary surgery for ovarian cancerC Tropé, J KaernEuropean Journal of Gynaecological Oncology|February 12, 1999
Carboplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-upT Paulsen, J Kaern, C TropéEuropean Journal of Cancer (Oxford, England : 1990)|November 1, 2000
Tamoxifen in the treatment of recurrent ovarian carcinomaC Tropé, C Marth, J KaernCancer Chemotherapy and Pharmacology|January 1, 1990
A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomasC Tropé, J Kaern, I Vergote, et al.Acta Oncologica (Stockholm, Sweden)|July 27, 1999
Long-term follow-up of neoadjuvant cisplatin and 5-fluorouracil chemotherapy in bulky squamous cell carcinoma of the cervixC Marth, K Sundfor, J Kaern, et al.European Journal of Gynaecological Oncology|August 15, 2001
Long-term results from a phase II study of paclitaxel combined with doxorubicin in recurrent platinum refractory ovarian cancerC Tropé, G Kristensen, J Kisic, et al.Gynecologic Oncology|March 1, 1996
Cisplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-upJ Kaern, C Tropé, K Sundfoer, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1997
Paclitaxel in untreated FIGO stage III suboptimally resected ovarian cancerC Tropé, J Kaern, G Kristensen, et al.Pageof 18